Trade Mark Journal No.2025/027 4 July 2025
WO0000001860364 (5,35,42,44)
Office of origin: Benelux Office for Intellectual Property (BOIP)
Date of International Registration:10 March 2025
Date of designation in the UK:
10 March 2025
International priority date claimed: 16 September 2024
(Benelux Office for Intellectual Property (BOIP))
(1510907)
- Class 5
- Pharmaceuticals and medical preparations for therapeutic purposes in the field of immunology and autoimmune diseases; pharmaceutical preparations for the prevention or treatment of autoimmune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, and transplantation-related diseases and disorders, cancer and diseases of the immune system; compositions of antibodies or fragments of antibodies or derivatives of antibodies with therapeutic properties; antibodies or fragments of antibodies or derivatives of antibodies for the prevention or treatment of autoimmune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, transplantation-related diseases and disorders, cancer and diseases of the immune system.
- Class 35
- Wholesale and retail services for therapeutic pharmaceutical preparations in the field of immunology and auto-immune diseases and antibodies or fragments or derivatives of antibodies with therapeutic properties; administrative services in relation to patient information in the field of immunology, diseases of the immune system and antibody therapeutics; administration of patient reimbursement programs.
- Class 42
- Research and development in the field of immunology, antibody engineering and autoimmune diseases for therapeutic purposes; therapeutic drug research and development in the field of immunology, antibody technology and autoimmune diseases; scientific and technological services and research relating to immunity, autoimmune diseases and antibody engineering for therapeutic purposes; providing medical and scientific research information in the field of therapeutic pharmaceuticals, clinical trials, research and development.
- Class 44
- Providing information to patients in the field of auto-immune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, and transplantation-related diseases and disorders, cancer and diseases of the immune system and the treatment thereof; consultancy and information services relating to therapeutic biopharmaceutical products; provision of information on therapeutic pharmaceutical, medical, and healthcare products to customers or patients through an online computer network.
Argenx
Representative: GEVERS, De Kleetlaan 7 A (4de verdieping), , Pegasus Park, B-1831 Diegem, BELGIUM